BRAF targeted therapy changes the treatment paradigm in melanoma.

Abstract excerpt

After decades of stagnation, recent therapeutic advances in melanoma seem on the horizon. The discovery of the genetic underpinnings of this historically refractory disease has exposed potential targets for therapy, BRAF mutations being principal among them. In the 8 years following the discovery of BRAF mutations in 50-60% of advanced melanomas, only recently have potent and selective inhibitors of this...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to BRAF gene
• Share to Indoles
• Share to Melanoma